This can be done by binding to the enzyme's active site or by indirectly acting as an antioxidant and scavenging free radicals
Agenda Co-chairs Dr Luz de Regil Director, Department of Nutrition and Food Safety, WHO and Dr Kirsten Bibbins Domingo Editor-in-Chief, JAMA Moderator Dr Gaya Manori Gamhewage, Director, Department of Communication, WHO Welcoming Dr Luz De Regil Director NFS, WHO and Dr Kirsten Bibbins-Domingo, Editor-in-Chief, JAMA Presentation: WHO guideline on the use of glucagon-like peptide-1 (GLP-1) therapies for the treatment of obesity in adults Dr Francesca Celletti, Senior Advisor Obesity, Department of Nutrition and Food Safety, WHO and Dr
What Has Been Studied
When urinary changes do occur, they are more likely related to indirect factors associated with the medication's primary effects rather than a direct pharmacological action on the urinary system
Surgery for Squamous Cell Cancer of the Esophagus: Only for Salvage or as Part of Combined Modality Therapy
Migration of V1 and V2 T cells in response to CXCR3 and CXCR4 ligands in healthy donors and HIV-1-infected patients: competition by HIV-1 Tat
